Concepedia

Publication | Closed Access

Efficacy and Safety of Recombinant Human Nerve Growth Factor in Patients With Diabetic Polyneuropathy

DOI

354

Citations

21

References

2000

Year

Stuart C. Apfel, Sherwin Schwartz, Bruce T. Adornato, Roy Freeman, Victor Biton, Marc Rendell, Aaron I. Vinik, Michael J. Giuliani, J. Clarke Stevens, Richard L. Barbano,
JAMA

Abstract

Unlike previous phase 2 trials, this phase 3 clinical trial failed to demonstrate a significant beneficial effect of rhNGF on diabetic polyneuropathy. JAMA. 2000;284:2215-2221.

References

YearCitations

Page 1